Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
NCT00757211 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2013-08-26
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This study is looking at genetic susceptibility to cancer and interactions between genes and the environment in patients with breast cancer.
Conditions
Interventions
- GENETIC
-
polymorphism analysis
- OTHER
-
laboratory biomarker analysis
- OTHER
-
questionnaire administration
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Paul Pharoah, MD · Cancer Research UK
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
NCT04265937 ·Status: RECRUITING
-
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
NCT01407770 ·Status: COMPLETED
-
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
NCT01992471 ·Status: COMPLETED
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer
NCT00047970 ·Status: COMPLETED
-
Biomarkers for Breast Cancer Risk in African American Women
NCT01736306 ·Status: COMPLETED
-
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
NCT01386411 ·Status: COMPLETED
-
Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer
NCT01199393 ·Status: COMPLETED
-
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
NCT00040222 ·Status: COMPLETED
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Study of Blood Samples in Patients With Breast Cancer
NCT00959556 ·Status: COMPLETED
-
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
NCT03319290 ·Status: UNKNOWN
-
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
NCT04920656 ·Status: COMPLETED
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
NCT02786147 ·Status: COMPLETED
-
Markers for Breast Cancer
NCT00339248 ·Status: COMPLETED
-
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
NCT05721326 ·Status: COMPLETED ·Phase: NA
-
Familial Breast Cancer in China
NCT06833216 ·Status: NOT_YET_RECRUITING
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED
-
The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach
NCT00393406 ·Status: COMPLETED
-
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 ·Status: RECRUITING
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies
NCT03880097 ·Status: NOT_YET_RECRUITING